Fondation Fournier-Majoie
Investor profile
Private equity
Fondation Fournier-Majoie has backed 2 European tech companies across 3 funding rounds between 2021 and 2024, joining rounds totalling €39M. Most active in Healthtech. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
2
backed
Active span
2021–2024
4 yrs
Total round €
€39M
sum of rounds joined
Deals by year
distinct rounds / yearFondation Fournier-Majoie — deals by year — interactive chart.
Data table
| Fondation Fournier-Majoie — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Top sectors
by dealsFondation Fournier-Majoie — top sectors — interactive chart.
Data table
| Fondation Fournier-Majoie — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsFondation Fournier-Majoie — stages — interactive chart.
Data table
| Fondation Fournier-Majoie — stages | |
|---|---|
| Seed | 2 |
| Series A | 1 |
Countries
by dealsFondation Fournier-Majoie — countries — interactive chart.
Data table
| Fondation Fournier-Majoie — countries | |
|---|---|
| France | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Mablink Bioscience | France | 2 | €35M |
| HEPHAISTOS-Pharma | France | 1 | €4.3M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Mablink Bioscience | Series A | €31M | 2022-10 |
| HEPHAISTOS-Pharma | Seed | €4.3M | 2024-05 |
| Mablink Bioscience | Seed | €4.0M | 2021-04 |